EPA

As of March 22, 2026, comprehensive searches across web and X yield no new federal OIG grant fraud audits, GAO FY2025 improper payments reports, or major scandals since March 21. State-level Medicaid fraud cases continue, including Ohio indictments of 10 providers and Dr. Oz's escalation of claims against Minnesota, but these do not involve new federal grant-specific revelations. Proactive federal and state measures, such as the March 19 Executive Order on Fraud Task Force and Minnesota's CMS-approved anti-fraud plan, remain in place without updates indicating setbacks.

2025 marked record-high lobbying expenditures by the pharmaceutical industry, with PhRMA spending nearly $38 million and total healthcare lobbying surging 16% to $653 million in the first three quarters, underscoring intensified influence amid regulatory shifts. Confirmed reverse revolving door appointments include Chainlink's Taylor Lindman as SEC Crypto Task Force Chief Counsel in February 2026 and Nancy Beck's ongoing senior role at EPA's chemical safety office; former Energy Secretary Jennifer Granholm expanded to Edison International's board alongside her DGA Group position. No major new forward revolving door placements for figures like ex-SEC Chair Gary Gensler as of March 2026, but the pattern persists with legislative efforts like H.R.3554 to curb it.